Population
Enzymatically disaggregated atrial and ventricular myocytes from transgenic mice and control animals
Comparison
Postnatal transgenic cardiac-specific… vs Myocytes from control animals
Design
Preclinical
Authors
Loading...
Animal data preclude clinical application; leaves open MLC2v modulation as a target for atrial contractility in humans.
Replacement of atrial myosin light chain-2 with the ventricular isoform enhances atrial myocyte contractility, suggesting MLC2v modulates chamber-specific contractility via enhanced calcium sensitivity or improved cross-bridge cycling.
Pawloski-Dahm et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: